Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 191   

Articles published

PFE 29.25 -0.22 (-0.73%)
price chart
Pfizer to buy Baxter's vaccines unit for $635 million
(Reuters) - Pfizer Inc (PFE.N) agreed on Wednesday to buy Baxter International Inc's (BAX.N) vaccines unit and a part of a production facility for $635 million.
Pfizer to buy Baxter's vaccines for $635 million  MarketWatch
Why Pfizer (PFE) Stock Is Down Today  TheStreet.com
Related articles »  
Pfizer's need for deal looms larger with earnings report
Investors still see a rationale for the deal, which would allow Pfizer to enjoy lower corporate tax rates as a UK-based company and a promising pipeline of new cancer treatments. Under British takeover law, AstraZeneca could reach out to Pfizer in ...
Pfizer leaves investors guessing on intentions for Astra
(Reuters) - Pfizer Inc, which in May abandoned its $118 billion bid for AstraZeneca Plc, on Tuesday left investors guessing whether it would renew its pursuit of its British rival, but said it was considering other deals.
Pfizer CEO Still Hunting for Deals and Willing to Go Big  Bloomberg
Related articles »  
Pfizer, Inc. (PFE) Tops Q2 EPS by 1c
Pfizer, Inc. (NYSE: PFE) reported Q2 EPS of $0.58, $0.01 better than the analyst estimate of $0.57. Revenue for the quarter came in at $12.8 billion versus the consensus estimate of $12.49 billion.
Is Pfizer Inc. (PFE) Poised to Beat Earnings Estimates? - Analyst Blog
Pfizer Inc. ( PFE ) is scheduled to report second quarter 2014 results before the opening bell on Jul 29. Why a Likely Positive Surprise?
Related articles »  
Pfizer Inc. (PFE) To Sweeten Bid for Astrazeneca plc (ADR) (AZN): Frost & Sullivan
Ranjith Gopinathan, who is a program manager, life sciences and healthcare practice at Frost & Sullivan during an interview on CNBC said that while Merck & Co.
Pfizer Inc share price up, posts steady Q2 revenue and profit, lowers outlook
Pfizer Inc, the leading US drugmaker, posted quarterly earnings today, revealing steady revenue and profit, with declining sales for major divisions and climbing R&D expenses.
Pfizer Q2 GAAP profit slumps, but results top street; backs 2014 Adj. EPS view  RTT News
Related articles »  
Pfizer Needs to Do a Deal, Analyst Says
Still, Mr. Boris predicts that without an acquisition by the end of 2015, only 38% of Pfizer's revenue will come from the U.S.
Pfizer Needs to Do a Deal, Analyst Says - PFE  Street Register
Related articles »  
Pfizer Inc. To Go Ex-Dividend on July 30th (PFE)
Pfizer logo Pfizer (NYSE:PFE) declared a quarterly dividend on Thursday, June 26th, American Banking and Market News reports.
Pfizer Inc.: Pfizer Enters Into Agreement to Acquire Baxter's Portfolio of ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. today announced that it has entered into a definitive agreement to acquire Baxter International Inc.'s portfolio of marketed vaccines for $635 million.